Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow Quality Index
Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow quality index. Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Cash Flow Quality Index of 2.87x as of December 2024. Operating cash flow of CN¥47.07 Million exceeds net income of CN¥16.41 Million, indicating high earnings quality where cash backs reported profits. Explore 301258 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Cash flow quality index of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. Historical Cash Flow Quality Index for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of Suzhou Fushilai Pharmaceutical Co. Ltd. to measure how much of total assets are equity-financed.
Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow Quality Index by Year (2019–2024)
Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Suzhou Fushilai Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see Suzhou Fushilai Pharmaceutical Co. Ltd. operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.87x | CN¥47.07 Million | CN¥16.41 Million | ▲ +239.6% |
| 2023 | 0.84x | CN¥94.77 Million | CN¥112.18 Million | ▼ -0.9% |
| 2022 | 0.85x | CN¥151.19 Million | CN¥177.30 Million | ▼ -48.7% |
| 2021 | 1.66x | CN¥199.73 Million | CN¥120.20 Million | ▲ +40.5% |
| 2020 | 1.18x | CN¥166.85 Million | CN¥141.05 Million | ▲ +14.5% |
| 2019 | 1.03x | CN¥150.55 Million | CN¥145.71 Million | — |